Active — Not RecruitingNot Applicable

Comprehensive SRS Regenerex Tissue Attachment

United States22 participantsStarted 2024-10-22

Plain-language summary

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
✓. Revision where other devices or treatments have failed.
✓. Correction of functional deformity.
✓. Oncology applications including bone loss due to tumor resection.

What they're measuring

Kaplan Meier Implant Survivorship

Timeframe: Up to 10 Years

Safety Assessement

Timeframe: Up to 10 Years

Trial details

NCT IDNCT06615739

SponsorZimmer Biomet

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Arthroplasty Complications trials